Imedex® is an industry leader in providing accredited, independent continuing medical education to health care professionals.
It is our pleasure to invite you to join us February 19 -21, 2015 in sunny San Diego, California for the The 17th Annual Symposium on Anti-Angiogenesis and Immune Therapies for Cancer: Recent Advances and Future Directions in Basic and Clinical Cancer Research.
Formerly known as the International Symposium on Anti-Angiogenic Agents, this meeting promises to be a first-class educational event that focuses on the latest Angiogenesis and Immune Therapies for Cancer.
Through didactic presentations, interactive panel discussions, and Q&A sessions, the conference will serve as a platform to discuss and evaluate many of the clinical challenges for optimal integration of antiangiogenesis and immune-modulating agents into existing treatment paradigms for cancer care, appropriate selection of patients based on biomarker profiles for individualized treatment strategies, and use of these agents in the adjuvant and advanced disease settings.
Topics will focus on cutting edge science in the field, highlighting novel strategies under clinical development, and include:
- Rationale for and mechanisms of action of novel anti-angiogenic and immune-targeted strategies
- Stromal therapy and targets in the tumor microenvironment
- Combination regimens
- Controversies with the new therapeutics, mechanisms of resistance, unique adverse events, and ongoing clinical trials
- Poster presentations
George W. Sledge, Jr., MD
Robert S. Kerbel, PhD
Lee M. Ellis, MD
Axel Grothey, MD
Helen X. Chen, MD
Elizabeth M. Jaffee, M.D.
|Early Registration Deadline||December 18, 2014|
|Abstract Submission Deadline||January 7, 2015|
|Abstract Notifications Mailed
||January 14, 2015|
|Abstract Presenter Registration Deadline||January 29, 2015|
|Discounted Registration Deadline||February 5, 2015|
|Presentation Dates||February 19 – 21, 2015|